Gremlin - A putative pathogenic player in progressive renal disease

Expert Opinion on Therapeutic Targets

Volumn 7, Issue 4, 2003, Pages 523-526

  Dolan, Vincent ^a   Murphy, Madeline ^a   Alarcon, Pilar ^a   Brady, Hugh R ^a   Hensey, Carmel ^a  

^a Dublin Molecular Medicine Centre   (Ireland)

Author keywords

Bone morphogenetic protein 7 (BMP 7); Diabetic nephropathy; drm; Gremlin; Nephrogenesis; Renal fibrosis

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN RECEPTOR; CONNECTIVE TISSUE GROWTH FACTOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBROBLAST GROWTH FACTOR; GREMLIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; OSTEOGENIC PROTEIN 1; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

CHRONIC KIDNEY FAILURE; DIABETIC NEPHROPATHY; DISEASE COURSE; DRUG TARGETING; GLOMERULOSCLEROSIS; KIDNEY CELL; KIDNEY DEVELOPMENT; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY HYPERTROPHY; KIDNEY INJURY; KIDNEY INTERSTITIUM; KIDNEY TUBULE; NONHUMAN; PATHOGENESIS; PROTEIN EXPRESSION; REVIEW; TREATMENT PLANNING;

EID: 0042329460     PISSN: 14728222     EISSN: None     Source Type: Journal    
DOI: 10.1517/14728222.7.4.523     Document Type: Review

References (35)

1. PETERS H, NOBLE NA, BORDER WA: Transforming growth factor-β in human glomerular injury. Curr. Opin. Nephrol. Hypertens. (1997) 6(4):389-393.
2. CLARKSON MR, GUPTA S, MURPHY M, MARTIN F, GODSON C, BRADY HR: Connective tissue growth factor: a potential stimulus for glomerulosclerosis and tubulointerstitial fibrosis in progressive renal disease. Curr. Opin. Nephrol. Hypertens. (1999) 8(5):543-548.
3. STRUTZ F, ZEISBERG M, ZIYADEH FN et al.: Role of basic fibroblast growth factor-2 in epithelial-mesenchymal transformation. Kidney Int. (2002) 61(5):1714-1728.
4. DOLAN, V, HENSEY C, BRADY HR: Diabetic nephropathy: renal development gone awry? Pediatr. Nephrol. (2003) 18(2):75-84.
5. LAPPIN DW, HENSEY C, MCMAHON R, GODSON C, BRADY HR: Gremlins, glomeruli and diabetic nephropathy. Curr. Opin. Nephrol. Hypertens. (2000) 9(5):469-472.
6. HSU DR, ECONOMIDES AN, WANG X, EIMON PM, HARLAND RM: The Xenopus dorsalizing factor Gremlin identifies a novel family of secreted proteins that antagonize BMP activities. Mol. Cell (1998) 1(5):673-683.
7. MERINO R, RODRIGUEZ-LEON J, MACIAS D, GANAN Y, ECONOMIDES AN, HURLE JM: The BMP antagonist Gremlin regulates outgrowth, chondrogenesis and programmed cell death in the developing limb. Development (1999) 126(23):5515-5522.
8. TOPOL LZ, MARX M, LAUGIER D: Identification of drm, a novel gene whose expression is suppressed in transformed cells and which can inhibit growth of normal but not transformed cells in culture. Mol. Cell. Biol. (1997) 17(8):4801-4810.
9. MCMAHON R, MURPHY M, CLARKSON M et al.: IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-β1. J. Biol. Chem. (2000) 275(14 ):9901-9904.
10. BALEMANS W, VAN HUL W: Extracellular regulation of BMP signaling in vertebrates: a cocktail of modulators. Dev. Biol. (2002) 250(2):231-250.
11. SHI W, ZHAO J, ANDERSON KD et al.: Gremlin negatively modulates BMP-4 induction of embryonic mouse lung branching morphogenesis. Am. J. Physiol. Lung Cell. Mol. Physiol. (2001) 280(5):1030-1039.
12. LU MM, YANG H, ZHANG L, SHU W, BLAIR DG, MORRISEY EE: The bone morphogenic protein antagonist gremlin regulates proximal-distal patterning of the lung. Dev. Dyn. (2001) 222(4):667-680.
13. ZUNIGA A, HARAMIS AP, MCMAHON AP, ZELLER R: Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. Nature (1999) 401(6753):598-602.
14. MASS RL, ZELLER R, WOYCHIK RP, VOGT TF, LEDER P: Disruption of formin-encoding transcripts in two mutant limb deformity alleles. Nature (1990) 346(6287):853-855.
15. DUDLEY AT, LYONS KM, ROBERTSON EJ: A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye. Genes Dev. (1995) 9(22):2795-2807.
16. DUDLEY AT, GODIN RE, ROBERTSON EJ: Interaction between FGF and BMP signaling pathways regulates development of metanephric mesenchyme. Genes Dev. (1999) 13(12):1601-1613.
17. KARSENTY G, LUO G, HOFMANN C, BRADLEY A: BMP 7 is required for nephrogenesis, eye development, and skeletal patterning. Ann. NY Acad. Sci. (1996) 785:98-107.
18. MIYAZAKI Y, OSHIMA Y, FOGO A, HOGAN BL, ICHIKAWA I: Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J. Clin. Invest. (2000) 105(7):863-873.
19. PISCIONE TD, YAGER TD, GUPTA IR et al.: BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis. Am. J. Physiol. (1997) 273(6 Pt 2):F961-F975.
20. DUNN NR, WINNIER GE, HARGETT LK, SCHRICK JJ, FOGO AB, HOGAN BL: Haploinsufficient phenotypes in Bmp4 heterozygous null mice and modification by mutations in Gli3 and Alx4. Dev. Biol. (1997) 188(2):235-247.
21. DOLAN V, HENSEY C, MARTIN F, BRADY HR: Gremlin and the developing xenopus pronephros. J. Am. Soc. Nephrol. (2002) 13(SA-FC124).
22. MURPHY M, MACMAHON R, CLARKSON M et al.: Induction of gremlin expression in the remnant kidney in vivo and during TGF-induced epithelial mesenchymal transformation in vitro. J. Am. Soc. Nephrol. (2000) 11(3298A).
23. SIMON M, MARESH JG, HARRIS SE et al.: Expression of bone morphogenetic protein-7 mRNA in normal and ischemic adult rat kidney. Am. J. Physiol. (1999) 276(3 Pt 2):F382-F389.
24. WANG SN, LAPAGE J, HIRSCHBERG R: Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. (2001) 12(11):2392-2399.
25. ALMANZAR MM, FRAZIER KS, DUBE PH et al.: Osteogenic protein-1 mRNA expression is selectively modulated after acute ischemic renal injury. J. Am. Soc. Nephrol. (1998) 9(8):1456-1463.
26. HRUSKA KA, GUO G, WOZNIAK M et al.: Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol. Renal Physiol. (2000) 279(1):F130-F143.
27. MORRISSEY J, HRUSKA K, GUO G, WANG S, CHEN Q, KLAHR S: Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J. Am. Soc. Nephrol. (2002) 13(Suppl. 1):S14-S21.
28. GOULD SE, DAY M, JONES SS, DORAI H: BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. (2002) 61(1):51-60.
29. MURPHY M, GODSON C, CANNON S et al.: Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J. Biol. Chem. (1999) 274(9):5830-5834.
30. WANG SN, LAPAGE J, HIRSCHBERG R: Role of glomerular ultrafiltration of growth factors in progressive interstitial fibrosis in diabetic nephropathy. Kidney Int. (2000) 57(3):1002-1014.
31. SHARMA K, ZIYADEH FN: Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-β as a key mediator. Diabetes (1995) 44(10):1139-1146.
32. RISER BL, LADSON-WOFFORD S, SHARBA A et al.: TGF-β receptor expression and binding in rat mesangial cells: modulation by glucose and cyclic mechanical strain. Kidney Int. (1999) 56(2):428-439.
33. TOPOL LZ, BARDOT B, ZHANG Q et al.: Biosynthesis, post-translation modification, and functional characterization of Drm/Gremlin. J. Biol. Chem. (2000) 275(12):8785-8793.
34. CHEN B, ATHANASIOU M, GU Q, BLAIR DG: Drm/Gremlin transcriptionally activates p21 (Cip1) via a novel mechanism and inhibits neoplastic transformation. Biochem. Biophys. Res. Commun. (2002) 295(5):1135-1141.
35. MONKAWA T, HIROMURA K, WOLF G, SHANKLAND SJ: The hypertrophic effect of transforming growth factor-β is reduced in the absence of cyclin-dependent kinase-inhibitors p21 and p27. J. Am. Soc. Nephrol. (2002) 13(5):1172-1178.